#lupin
Lupin eyes $500 mn biosimilars revenue in medium term, to ramp capacity
The company plans to soon start the funding process for its oncology spin-off, Kaveri Therapeutics, which houses two specialised oncology programmes
Lupin Announces the Approval of Diazepam Injection, USP in the United States
MUMBAI, India, and NAPLES, Fla., July 28, 2026 /PRNewswire/ -- Global pharmaceutical leader Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced that it has received approval under the Federal Food, Drug, and…
Trade Spotlight : How should you trade GAIL , Action Construction Equipment , Niva Bupa Health , ITC Hotels , Lupin , Vardhman Textiles , and others on June 19 ?
Stocks to Watch Today : Physicswallah , Swiggy , Q - Line Biotech , Lupin , Wockhardt , Ashok Leyland , GMR Airports , PG Electroplast , West Coast Paper in focus on 29 May
Buzzing stocks: Anupam Rasayan, Bliss GVS, Oil India, NBCC, RVNL, Lupin, Aurobindo Pharma, Goodluck, PNC Infra, Sterlite Tech, CBI and others
Explore major stock developments involving Anupam Rasayan, Bliss GVS, Oil India, and more in this concise market overview.
Lupin Receives China Approval for Oseltamivir Phosphate Oral Suspension
Marks Lupin's Debut in the Chinese Market MUMBAI, India and BEIJING and NAPLES, Fla., May 22, 2026 /PRNewswire/ -- Global pharmaceutical leader Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced that China'…
Lupin Receives China Approval for Oseltamivir Phosphate Oral Suspension
Marks Lupin's Debut in the Chinese Market MUMBAI, India and BEIJING, May 22, 2026 /PRNewswire/ -- Global pharma major Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced that China's National Medical Product…
Lupin Receives China Approval for Oseltamivir Phosphate Oral Suspension
Marks Lupin's Debut in the Chinese Market MUMBAI, India and BEIJING, May 22, 2026 /PRNewswire/ -- Global pharma major Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced that China's National Medical Product…
Lupin Receives Tentative Approval from U.S. FDA for Revefenacin Inhalation Solution
MUMBAI, India, NAPLES, Fla, May 18, 2026 /PRNewswire/ -- Global pharmaceutical leader Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced that it has received tentative approval from the United States Food a…
Lupin Receives U.S. FDA Approval for Famotidine Injection, USP
MUMBAI, India and NAPLES, Fla, May 13, 2026 /PRNewswire/ -- Global pharmaceutical leader Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced that it has received approval from the United States Food and Drug…
Lupin Receives U.S. FDA Approval for Glycerol Phenylbutyrate Oral Liquid
MUMBAI, India and NAPLES, Fla, May 5, 2026 /PRNewswire/ -- Global pharmaceutical leader Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced that it has received approval from the United States Food and Drug …
Why Sun Pharma’s massive Organon buyout is winning over investors where Lupin, Biocon failed
Sun Pharma’s acquisition of Organon marks a pivot toward biosimilars, utilizing a cheap valuation and strong cash reserves to avoid the chronic post-merger stock slumps seen by Indian rivals.